WebApr 4, 2024 · BERKELEY, Calif. and MAINZ, Germany, April 04, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today that three German-based companies have selected ColoAlert ®, the … WebApr 10, 2024 · Year End Cash Balance of $17.1 Million. BERKELEY, Calif. and MAINZ, Germany, April 10, 2024 (GLOBE NEWSWIRE) — Mainz Biomed N.V. MYNZ (“Mainz …
Mainz Biomed Expands Corporate Health Program for ColoAlert …
WebAbout us. Mainz Biomed is aiming to become a leading provider of easy-to-use diagnostic solutions for patients everywhere. We develop innovative products that quickly and easily … WebApr 10, 2024 · Early identification of Cancer saves lives. To be effective, cancer detection needs to be simple, readily available, and affordable. We develop innovative products … OUR BUSINESS CONCEPT & PIPELINE SAVES LIVES AND HEALTH CARE … COLOALERT TARGET CONDITION COLORECTAL CANCER 37 … Mainz BioMed is developing proprietary genetic testing methods for pancreatic … NEWS English / EnglischGerman / Deutsch All Corporate News All All Corporate … CONTACT CONTACT US To contact us send us a message using the form or … CAREERS CAREERS At Mainz BioMed, every day is about making a difference … flixbus uk office
Mainz Biomed to Present at Sidoti Virtual Investor Conference …
WebApr 10, 2024 · BERKELEY, US – MAINZ, Germany – April 10, 2024 — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic … Web2 days ago · 11.04.2024 - Die Aktien von Mainz Biomed (WKN: A3C6XX) sind zum Wochenauftakt um -6% abgerutscht und starten am Dienstag aber wieder mit Schwung (+1,3%) in den US-Handel. Anleger hatten sich von ... WebApr 10, 2024 · Year End Cash Balance of $17.1 Million. BERKELEY, Calif. and MAINZ, Germany, April 10, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular ... great grandad christmas card